Zofran®

DRUG2 trials

Sponsors

Teva Pharmaceuticals USA

Conditions

Healthy

Phase 1

Ondansetron HCl Orally Disintegrating Tablets Under Fasting Conditions

CompletedNCT00934180

Teva Pharmaceuticals USAHealthy

Start: 2002-12-31End: 2002-12-31Updated: 2024-08-21

Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions

CompletedNCT00934921

Teva Pharmaceuticals USAHealthy

Start: 2003-02-28End: 2003-02-28Updated: 2024-08-21